According to Fox, AT&T and Time Warner attorneys questioned the method and motivation behind a consulting firm’s research used as a key factor in the government’s lawsuit to stop AT&T and Time Warner’s merger.
Stefan Bewley, a director at the San Francisco-based consulting firm Altman Vilandrie & Company, was called to the stand by the Justice Department (DOJ) to discuss his firm’s research, which was conducted last year on behalf of Charter, a cable and broadband company that is publicly opposed to AT&T’s proposed US$85 billion takeover of Time Warner.
The study was commissioned in November of 2016, about a month after AT&T announced the merger. It looked at many networks and included Charter’s potential subscriber loss if it were to lose Turner Broadcasting, a division of Time Warner that includes channels such as TNT, TBS and CNN.
The findings were also a key factor in the study conducted by U.C. Berkeley professor Carl Shapiro, who is serving as an expert witness for the government in the trial. Shapiro’s analysis found that a combined AT&T and Time Warner company could cause cable prices to increase by about 45 US cents per month, per subscriber.
Under direct questioning from DOJ attorney Craig Conrath, Bewley said that his research found that Charter could suffer a 9% subscriber loss due to a Turner blackout — when a distributor drops access to a channel during carriage negotiations.
Using that 9% rate, Shapiro came to his conclusion about the price increase should the merger go through.
But during cross-examination with AT&T and Time Warner lead attorney Dan Petrocelli, Bewley acknowledged that initially the 9% result was actually 5%.
Full Content: Fox 2 Now
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas